famotidine

Generic: famotidine

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name famotidine
Generic Name famotidine
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 40 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 43063-696
Product ID 43063-696_4147b115-910a-13aa-e063-6394a90ad9e9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075805
Listing Expiration 2026-12-31
Marketing Start 2001-04-16

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43063696
Hyphenated Format 43063-696

Supplemental Identifiers

RxCUI
284245
UPC
0343063696958
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name famotidine (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA075805 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (43063-696-30)
  • 90 TABLET in 1 BOTTLE, PLASTIC (43063-696-90)
  • 180 TABLET in 1 BOTTLE, PLASTIC (43063-696-93)
  • 1000 TABLET in 1 BOTTLE, PLASTIC (43063-696-95)
source: ndc

Packages (4)

Ingredients (1)

famotidine (40 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4147b115-910a-13aa-e063-6394a90ad9e9", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0343063696958"], "unii": ["5QZO15J2Z8"], "rxcui": ["284245"], "spl_set_id": ["09ef39a4-c6b3-4395-8211-3f551dc44830"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-696-30)", "package_ndc": "43063-696-30", "marketing_start_date": "20160726"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (43063-696-90)", "package_ndc": "43063-696-90", "marketing_start_date": "20160726"}, {"sample": false, "description": "180 TABLET in 1 BOTTLE, PLASTIC (43063-696-93)", "package_ndc": "43063-696-93", "marketing_start_date": "20160726"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE, PLASTIC (43063-696-95)", "package_ndc": "43063-696-95", "marketing_start_date": "20210511"}], "brand_name": "Famotidine", "product_id": "43063-696_4147b115-910a-13aa-e063-6394a90ad9e9", "dosage_form": "TABLET", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "43063-696", "generic_name": "Famotidine", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/1"}], "application_number": "ANDA075805", "marketing_category": "ANDA", "marketing_start_date": "20010416", "listing_expiration_date": "20261231"}